Related Experiment Videos
Response to treatment in panic disorder with associated depression
1Department of Psychiatry, University of California, Davis.
Psychopathology
|January 1, 1991
Summary
This study found that patients with panic disorder (PD) and a history of secondary major depressive disorder (MDD) had good treatment outcomes, similar to those without MDD history. However, primary MDD history correlated with poorer PD treatment results.
Area of Science:
- Psychiatry
- Clinical Psychology
- Mental Health Research
Background:
- Panic disorder (PD) is a significant mental health concern.
- The comorbidity of major depressive disorder (MDD) with PD can complicate treatment and prognosis.
- Understanding the impact of different MDD histories on PD treatment is crucial for effective clinical management.
Purpose of the Study:
- To investigate the treatment outcomes of panic disorder (PD) in relation to the history of major depressive disorder (MDD).
- To differentiate the prognostic impact of primary versus secondary MDD on PD treatment success.
Main Methods:
- A cohort of 30 outpatients diagnosed with panic disorder (PD) was recruited from an anxiety clinic.
- Patients were treated using a symptom-focused therapeutic approach.
- Data on the history of major depressive disorder (MDD) – primary, secondary, or none – were collected and analyzed in relation to treatment outcomes.
Main Results:
- Outcomes were assessed for 30 outpatients with PD.
- 77% of patients with no MDD history and 83% with secondary MDD history achieved good or excellent outcomes.
- Patients with a history of primary MDD exhibited the poorest treatment outcomes.
Conclusions:
- The presence of secondary major depressive disorder (MDD) does not appear to negatively impact the prognosis for patients undergoing treatment for panic disorder (PD).
- Conversely, a history of primary MDD is associated with less favorable outcomes in PD treatment.
- These findings support existing research suggesting that the specific type of comorbid depression influences PD treatment efficacy.